DeniLA: Comprehensive demographics and clinical profile of NSCLC patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns

Trial Identifier: D133FR00224
Sponsor: AstraZeneca
Start Date: November 2025
Primary Completion Date: April 2027
Study Completion Date: April 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil, Bahia Salvador, Bahia, Brazil
Brazil, Pernambuco Recife, Pernambuco, Brazil
Brazil, Rio de Janeiro Rio de Janeiro, Brazil
Brazil, São Paulo São Paulo, Brazil